Intellectual Property and Research

---

​Intellectual Property

University of Massachusetts Patent #10,383,888
Exopolysaccharide for Inflammatory Disease [HT-01]
Issued August 20, 2019

Publications

Jones SE, Knight KL. Bacillus subtilis-mediated protection from Citrobacter rodentium-associated enteric disease requires espH and functional flagella. Infect Immun. 2012;80(2):710-719. doi:10.1128/IAI.05843-11
 
Jones SE, Paynich ML, Kearns DB, Knight KL. Protection from intestinal inflammation by bacterial exopolysaccharides. J Immunol. 2014;192(10):4813-4820. doi:10.4049/jimmunol.1303369

Paynich ML, Jones-Burrage SE, Knight KL. Exopolysaccharide from Bacillus subtilis Induces Anti-Inflammatory M2 Macrophages That Prevent T Cell-Mediated Disease. J Immunol. 2017;198(7):2689-2698. doi:10.4049/jimmunol.1601641
 
Kalinina O, Talley S, Zamora-Pineda J, Paik W, Campbell EM, Knight KL. Amelioration of Graft-versus-Host Disease by Exopolysaccharide from a Commensal Bacterium. J Immunol. 2021;206(9):2101-2108. doi:10.4049/jimmunol.2000780